Pet Sitting Global Market Report 2023 – By Pet Type (Dogs, Cats, Fish, Cage Pets, Other Pet Types), By Service (In-House Sitting, At-Care Facilities), By Application (Day Care Visits, Dog Walking, Pet Transportation, Other Applications) – Market Size, Trends, And Global Forecast 2023-2032

The wearable medical devices market consists of sales of wearable medical equipment and related services that includes diagnostic devices and therapeutic devices like vital signs, sleep and neuro monitoring devices, electrocardiographs, pain management, respiratory therapeutic devices among others. The companies involved in wearable medical devices market design, manufacture and market medical wearables like watches, wristbands, clothing, ear wear and other devices for the applications like Remote Patient Monitoring, Ear wear, Home healthcare, Sports and Fitness which are designed for patient management and life-style disease management like prevention of diseases and maintenance of health with advantages such as weight control and physical activity monitoring.

Wearable injectors are drug delivery devices that adhere to the body while the drug is administered subcutaneously over a preset time period. The main types of wearable injectors are on-body injectors and off-body injectors. On-body injectors are drug delivery devices that are applied directly to the patient’s skin, in the abdominal region or the back of the patient’s arm. The various applications include immuno-oncology, diabetes, cardiovascular diseases, and others that are used by various end-users such as hospitals, clinics, and home care settings. The global wearable injectors market is segmented - 1) By Type: On-Body Injectors, Off-Body Injectors 2) By End-User: Hospitals, Clinics, Homecare setting 3) By Application: Immuno-Oncology, Diabetes, Cardiovascular Diseases, Other Applications The global wearable injectors market size grew from $7.16 billion in 2022 to $7.98 billion in 2023 at a compound annual growth rate (CAGR) of 11.4%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the wearable injectors is expected to grow from $12.93 billion in 2027 at a CAGR of 12.8%. The rise in the number of diabetic and chronic diseases patients such as cardiovascular diseases and cancers contributed to the growth of the wearable injectors market. According to the International Diabetes Federation, in 2021, approximately 537 million adults were living with diabetes, and by 2045, it is estimated that around 783 million adults around the world and 1 in 5 adults who are above 65 are expected to suffer from diabetes. The rise in the number of diabetes and chronic diseases patients increased the demand for the treatment of the diseases, thereby driving the wearable injectors market growth. Major players in the wearable injectors market are Amgen, Becton, Dickinson, and Co., Enable Injections, Insulet Corporation, Ypsomed, Medtronic, Tandem Diabetes Care, Valeritas, and West Pharmaceutical Services. The high cost associated with wearable injectors is expected to limit the growth of the wearable injectors market. According to Drug Development and Delivery, wearable injectors are single-use systems that are comfortably worn on the body that costs between $20 to $35 per unit, which is high. The high cost associated with wearable injectors has a negative impact on the wearable injectors market growth. The focus areas for many companies in the wearable injectors manufacturing market have shifted to increasing mergers and acquisitions to acquire more production capabilities. Large prime manufacturers are forming joint ventures or buying small or midsized companies to acquire new capabilities or gain access to new markets. For instance, in April 2020, Zealand Pharma completed its acquisition of Valeritas, Inc., to expand the product portfolios and capabilities of the company. The acquisition is expected to build Zealand Pharma's capabilities and significantly increase its market share in the market. For instance, in April 2020, Zealand Pharma completed its acquisition of Valeritas, Inc., with an undisclosed amount. This acquisition helps to expand the product portfolios and capabilities of the company and is expected to build Zealand Pharma's capabilities and to importantly increase its market share in the market. Valeritas is a medical technology company committed to improving and commercializing creative drug delivery solutions. In April 2020, Copenhagen-based Zealand Pharma, a company that develops therapies for gastrointestinal, metabolic diseases, acquired Valeritas a New Jersey-based company that developed wearable insulin delivery devices for a deal amount of $23 million, plus the assumptions of some liabilities. The acquisition is expected to expand the footprint of Zealand Pharma in the US diabetes market. Valeritas, Inc. is a medical technology company headquartered in the United States. North America was the largest region in the wearable injectors market in 2022. Western Europe was the second-largest region in the global wearable injectors market analysis. The regions covered in the global wearable injectors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the wearable injectors market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The wearable injectors market consists of sales of instruments such as on-body injectors and off-body injectors. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The wearable injectors market research report is one of a series of new reports from The Business Research Company that provides wearable injectors market statistics, including wearable injectors industry global market size, regional shares, competitors with a wearable injectors market share, detailed wearable injectors market segments, market trends and opportunities, and any further data you may need to thrive in the wearable injectors industry. This wearable injectors market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Animal growth promoters and performance enhancers refer to the substances that are added to feeds as supplements or injections to increase feed utilization and growth in farm animals, as well as veterinary medicinal products that are administered to healthy animals in order to favourably influence the yield, quality, and/or growth of animal products. The main types of animal growth promoters and performance enhancers are antibiotic growth promoters and non-antibiotic growth promoters. Antibiotic growth promoters refer to the promoters that will enhance the health of the animal and increase productivity. These include natural chemicals such as microbial products, prebiotics, and probiotics, yeast products, enzymes and herbs, oils, and spices. The different types of animals that use animal growth promoters and performance enhancers include poultry, swine, livestock, aquaculture, and other animals. The global animal growth promoters and performance enhancers market is segmented – 1) By Type: Antibiotic Growth Promoters, Non-Antibiotic Growth Promoters 2) By Animal Type: Poultry, Swine, Livestock, Aquaculture, Other Animals 3) By Nature of Chemicals: Microbial Products, Prebiotics And Probiotics, Yeast Products, Enzymes/Herbs, Oils And Spices The global animal growth promoters and performance enhancers market size will grow from $13.73 billion in 2022 to $14.65 billion in 2023 at a compound annual growth rate (CAGR) of 6.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global animal growth promoters and performance enhancers market size is expected to grow to $18.92 billion in 2027 at a CAGR of 6.6%. The growing demand for meat is a significant factor that will drive the market for animal growth promoters and performance enhancers. Animal growth promoters make the animal accumulate fat and weight, resulting in more meat production and a more expensive animal. Meat is a major protein source for many people around the world. According to a study by FAO, the production of meat has doubled in the last 30 years and increased four-fold since the mid-1960s. The production and consumption of meat are expected to continue to grow. By 2050, global meat consumption is projected to reach between 460 million and 570 million tons. This is expected to drive the animal growth promoters and performance enhancers market. Major players in the animal growth promoters and performance enhancers market are Merck Animal Health, Cargill, Royal DSM N.V., Vetoquinol S.A., Bupo Animal Health, Elanco Animal Health Inc., Alltech, Bayer Animal Health, Zoetis, and Bioniche Life Sciences. Strict rules set by the US and European governments on the use of animal growth promoters and performance enhancers are restricting the animal growth promoter and performance enhancers market. For instance, Zoetis, the largest producer of animal medicines, is banned from selling antibiotics that promote faster growth in animals in the US and Europe. The US FDA has implemented a regulation that bans the use of antibiotics as feed supplements to help livestock and poultry grow faster. These regulations are expected to negatively impact the growth of the animal growth promoters and performance enhancers market. Companies in the market are increasingly investing in phytogenics for higher efficiency of growth promoters through natural means. Phytogenics, sometimes also referred to as botanicals or phytobiotics, are plant-based feed additives utilised in animal nutrition. They are derived from herbs, spices, and extracts. Phytochemicals can be used in solid, dried, and ground form or as extracts, and can also be classified as essential oils and oleoresins depending on the process used to derive the active ingredients. The use of phytogenics promotes increased feed intake, improved gut function, prevention of diarrhea, and antimicrobial and antioxidative effects in livestock. Companies such as Delacon, Cargill, and BIOMIN have invested in phytogenics. In June 2020, Elanco acquired Bayer Animal Health for $7.6 billion. This acquisition is expected to help Elanco expand its product profile and reach for medicines for pets and livestock. Bayer Animal Health is a division of Bayer HealthCare. North America was the largest region in the animal growth promoters and performance enhancers market in 2022. Asia-Pacific was the second-largest region in the global animal growth promoters and performance enhancers market. The regions covered in the global animal growth promoters and performance enhancers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the animal growth promoters and performance enhancers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The animal growth promoters and performance enhancers market consists of sales of growth hormone medications, anabolic implants, bovine somatotropin, ß-agonists and probiotics. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The animal growth promoters and performance enhancers report is one of a series of new reports from The Business Research Company that provides animal growth promoters and performance enhancers market statistics, including animal growth promoters and performance enhancers industry global market size, regional shares, competitors with animal growth promoters and performance enhancers market share, detailed animal growth promoters and performance enhancers market segments, market trends and opportunities, and any further data you may need to thrive in the animal growth promoters and performance enhancers industry. This animal growth promoters and performance enhancers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Pet food is a type of feed prepared from ingredients such as grains, oilseed mill products, and meat products that are specifically formulated and intended for consumption by dogs or cats. The main types of pet food are dog and cat food and other pet food. Dog and cat food is food specifically formulated and intended for consumption by dogs, cats, and other related canines. Pet foods contain several ingredients, which include animal derivatives, plant derivatives, and synthetics. These products are made available through specialised pet shops, internet sales, hypermarkets, and other distribution channels. The global pet food market is segmented - 1) By Type: Dog And Cat Food, Other Pet Food 2) By Distribution Channel: Specialized Pet Shops, Internet Sales, Hypermarkets, Other Distribution Channels 3) By Ingredients: Animal Derivatives, Plant Derivatives, Synthetic Subsegments Covered: Dog Food, Cat Food The global pet food market size grew from $66.45 billion in 2022 to $72.02 billion in 2023 at a compound annual growth rate (CAGR) of 8.4%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of global pet food market is expected to grow to $94.97 billion in 2027 at a CAGR of 7.2%. The pet food manufacturing market's growth is aided by stable economic growth forecasted in many developed and developing countries. According to the International Monetary Fund (IMF), global GDP growth reached 3.3% in 2020 and 3.4% in 2021, both according to the IMF. Recovering commodity prices, after a significant decline in the historical period, are further expected to aid the market's growth. Developed economies are also expected to register stable growth during the forecast period. Additionally, emerging markets are expected to continue to grow slightly faster than developed markets in the forecast period. Stable economic growth is expected to increase investments in the end-user markets, thereby driving the market during the forecast period. Major companies in the market include Mars Incorporated, Nestle S.A., Diamond Pet Foods Inc., J.M. Smucker Company, Colgate-palmolive co, Hill's Pet Nutrition, General Mills, InVivo Animal Nutrition, and Health, Unicharm Corporation, and Ingredion Incorporated. The outbreak of COVID-19 disease (COVID-19) has acted as a massive restraint on the pet food manufacturing market in 2020 as supply chains were disrupted due to trade restrictions and consumption declined due to lockdowns imposed by governments globally. COVID-19 is an infectious disease with flu-like symptoms including fever, cough, and difficulty breathing. The virus was first identified in 2019 in Wuhan, Hubei province of the People’s Republic of China, and has spread globally, including Western Europe, North America, and Asia. Food and beverage manufacturers depend on the supply of raw materials from domestic and international suppliers. As many governments restricted the movement of goods across countries and locally, manufacturers had to halt production due to a lack of raw materials. Also, restrictions on the trade of non-essential goods and fear of contamination through manufacturing facilities contributed to the decline. The outbreak had a negative impact on businesses throughout 2020 and into 2021. However, it is expected that the pet food manufacturing market will recover from the shock over the forecast period as it is a "black swan" event and not related to ongoing or fundamental weaknesses in the market or the global economy. Pet food manufacturing companies are using automation technologies such as advanced production lines and software solutions to improve safety and operational efficiency. These technologies automate formulation, batching, drying, coating, and liquid delivery processes. This results in cost-effective processing and consistent product quality. For example, Champion Petfoods, a Canadian producer of pet food, has video-monitored production lines, with cooking processes connected through Rockwell hardware and software systems. It also uses bulk bins and conveying systems, votator heat exchangers, and advanced extrusion and drying systems. United Pet Group’s pet food manufacturing plant in St. Louis used FactoryTalk software from Rockwell Automation to reduce overtime by 10% and increase labor efficiency by 15%. North America was the largest region in the pet food market share in 2022. Western Europe was the second-largest region in the pet food market. The regions covered in the global pet food market analysis report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pet food market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, and Vietnam. The pet food market consists of sales of dry dog food, dog treats, wet dog food, wet cat food, dry cat food, cat treats, and other pet food. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The pet food research report is one of a series of new reports from The Business Research Company that provides pet food statistics, including pet food industry global market size, regional shares, competitors with pet food share, detailed pet food segments, market trends and opportunities, and any further data you may need to thrive in the pet food industry. This pet food research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Wearable medical devices are autonomous medical devices that can be worn by a person and perform functions such as medical monitoring and support. The main types of wearable medical devices are diagnostic devices and therapeutic devices. The diagnostic devices are used for diagnosing patient outcomes. The various product types include watches, wristbands, clothing, earwear, and other devices. These are used in sports and fitness, remote patient monitoring, home healthcare, and ear wear. The various distribution channels are pharmacies, online channels, and hypermarkets. The global wearable medical devices market is segmented - 1) By Device Type: Diagnostic Devices, Therapeutic Devices 2) By Product Type: Watch, Wristband, Clothing, Ear Wear, Other Devices 3) By Distribution Channel: Pharmacies, Online Channel, HyperMarkets 4) By Application: Sports And Fitness, Remote Patient Monitoring, Home Healthcare, Ear Wear The global wearable medical devices market size will grow from $22.44 billion in 2022 to $27.37 billion in 2023 at a compound annual growth rate (CAGR) of 21.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global wearable medical devices market size is expected to grow to $60.48 billion in 2027 at a CAGR of 21.9%. The wearable medical devices market covered in this report is segmented by device type into diagnostic devices, therapeutic devices. It is also segmented by product type into watch, wristband, clothing, ear wear, other devices, by distribution channel into pharmacies, online channel, hypermarkets and by application into sports and fitness, remote patient monitoring, home healthcare, ear wear. Major players in the wearable medical devices market are Philips, Polar Electro, Omron Corporation, Fitbit Inc., Garmin Ltd., LifeWatch AG (BioTelemetry Inc.), Xiaomi Inc., VitalConnect, Jawbone Inc., General Electric Co., and Medtronic PLC. The rise in mortality rate due to non-communicable diseases with an increasing prevalence of chronic diseases and lifestyle-associated diseases like hypertension and diabetes contributed to the growth of wearable medical devices. The Healthcare industry is coming up with newer technologies to overcome this with necessary measures like continuous and remote patient monitoring facilities through wearables which can be worn over the body all-day long for continuous monitoring of the required parameters like vital signs, glucose levels, and more. According to the world health organization (WHO), 2020, Non-communicable diseases (NCDs) will estimate 80% of the global disease burden. Seven out of every ten deaths in developing countries are caused by NCDs, and around half of these deaths are in people younger than 70 years. Moreover, the global NCD burden will rise by 17% in the next decade, and in Africa., it will grow by 27%. According to the International Diabetes Federation, an international organization working for spreading awareness regarding diabetes, in 2021, 537 million adults were living with diabetes. This number is expected to increase to 643 million by 2030 and 783 million by 2045. The rise in the number of chronic diseases coupled with growing awareness among the people is pushing them towards continuous monitoring which boosted the wearable medical devices market growth. Wearable device manufacturers collect and store data to sell them to the customer itself by charging a certain amount on monthly basis or periodically as per the requirement or to third parties at places where this information is not considered as Protected Health Information. There is a higher exposure of sensitive data as the amount of data handled by Medical Internet of Things devices is growing exponentially. The major data privacy concerns arise during the transmission of data to a cloud and during its storage. In July 2022, according to a survey released by American Medical Association (AMA), a US-based healthcare association, 92% of the respondents were in favour of maintaining their privacy and agreed that the medical data should not be sold to companies. There are risks of the access and security of the personal information collected by the third-party healthcare service providers which are expected to hamper the growth of the wearable medical devices market during the forecast period. Integrating artificial intelligence into wearable medical devices is gaining traction. The data collected by wearable medical devices lack value without the integration of artificial intelligence (AI) that better utilizes the data collected. AI doctor which is a standalone network with a deep learning algorithm performs well than trained medical practitioners in conditions like skin lesions, electrocardiograms, medical imaging, and pathology. In 2020, Apple acquired Xnor.ai that develops technology like artificial intelligence to gain access to low-power AI tools for image recognition in wearables and others. A survey published in 2022 showed that 88% of the respondents were aware about AI. 46% of the respondents believed that the benefits of AI in healthcare outweighed the risk while only 2% agreed the opposite. The wearable device app developers are increasingly focused on integrating AI into the apps to analyze the remotely collected data for better interpreting the ailment by an AI doctor. North America was the largest region in the wearable medical devices market in 2022. Asia-Pacific was the second-largest region in the global wearable medical devices market analysis. The regions covered in the global wearable medical devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the wearable medical devices market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and USA. The wearable medical devices market consists of sales of wearble ECG monitors, wearable fitness tracker, biosensors and others that are wearable and are used for monitoring medical conditions. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The wearable medical devices market research report is one of a series of new reports from The Business Research Company that provides wearable medical devices market statistics, including wearable medical devices industry global market size, regional shares, competitors with a wearable medical devices market share, detailed wearable medical devices market segments, market trends and opportunities, and any further data you may need to thrive in the wearable medical devices industry. This wearable medical devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Wearable ECG monitors are portable medical devices that record electrical signals from the heart and help in detecting medical conditions related to the heart. The main types of wearable ECG monitors are wired and wireless. The wired wearable ECG monitors refer to the devices that keep track of heart rhythm and operated on a wire. These are of various grades such as consumer and clinical. These are used in applications such as atrial fibrillation, angina, atherosclerosis, cardiac dysrhythmia, congestive heart failure (CHF), coronary artery disease, heart attack, bradycardia, and tachycardia available at various sales channels such as online and pharmacy. The global wearable ECG monitors market is segmented - 1) By Type: Wired, Wireless 2) By Application: Atrial fibrillation, Angina, Atherosclerosis, Cardiac dysrhythmia, Congestive heart failures (CHF), Coronary artery disease, Heart attack, Bradycardia, Tachycardia 3) By Grade: Consumer, Clinical 4) By Sales Channel: Online, Pharmacy The global wearable ecg monitors market size will grow from $2.70 billion in 2022 to $3.29 billion in 2023 at a compound annual growth rate (CAGR) of 21.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the global wearable ecg monitors is expected to grow to $7.26 billion in 2027 at a CAGR of 21.9%. With the increasing incidence of cardiovascular diseases (CVD), there has been a growing interest in developing wearable devices that can continuously monitor cardiac activity. According to According to the Centers for Disease Control and Prevention, one person dies every 36 seconds in the USA from CVD. CVD account for nearly 836,546 deaths in the US alone. In 2020, about 697,000 people in the US died due to heart disease. Cardiovascular diseases that include abnormalities in heart rhythm such as atrial fibrillation, ventricular fibrillation, and atrioventricular block require long-term monitoring. Additionally, since the mortality rate is high in CVD patients, the need for wearable devices that enable continuous heart monitoring is critical. The increasing incidence of cardiovascular diseases is therefore driving the market for wearable ECG monitors for quick emergency response and earlier detection of heart malfunctioning. Major players in the wearable ECG monitor market are Apple, GE Healthcare, Withings, Samsung, QardioCore, AliveCor, Fitbit, Welch Allyn, Philips Healthcare, and CardioNet. Wearable ECG monitors employ electrodes that contact the skin directly to monitor the health state and signal/trigger alarm to the care providers. However, currently, the requirement is the electrodes that are non-contact with the human body. This is because by using the electrodes that are in contact with the human body, the body's movement may be easily superimposed on the detected ECG signal, and for steady monitoring of ECG signal, it is necessary to effectively remove the motion artifact from the ECG signal. Therefore, wearable ECG monitors employing electrodes in contact with a human body and causing motion artifacts are likely to challenge the wearable ECG monitor market. Prolonged ambulatory rhythm monitoring is crucial for the diagnosis of intermittent arrhythmia. Conventional technologies for non-invasive rhythm monitoring include Holter monitoring or external cardiac event recorders. However, these traditional technologies have limitations in terms of low sensitivity, low diagnostic yield, and poor patient compliance. Although implantable cardiac monitors (ICMs) help in long-term monitoring, it is an invasive method as it requires minor surgery and is also associated with significant costs. Therefore, there is an increasing demand for non-invasive ambulatory rhythm monitoring. Smart clothing technology is a novel, alternative tool for non-invasive ambulatory rhythm monitoring. In January 2021, Boston Scientific, a US-based medical technology company, acquired preventice solutions for $925 million. The acquisition would help Boston Scientific in growing its footprint in cardiac diagnostics and services vertical. Preventice solutions is a US-based company manufacturing wearable cardiac sensors for remote patient monitoring. Western Europe was the largest region in the wearable ECG monitor market in 2022. North America was the second-largest region in the global wearable ECG monitors market share. The regions covered in the global wearable ECG monitor market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the wearable ECG monitor market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The wearable ECG monitors market consist of sales of wired and wireless wearable ECG monitors. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The wearable ECG monitor market research report is one of a series of new reports from The Business Research Company that provides wearable ECG monitor market statistics, including wearable ECG monitor industry global market size, regional shares, competitors with a wearable ECG monitor market share, detailed wearable ECG monitor market segments, market trends and opportunities, and any further data you may need to thrive in the wearable ECG monitor industry. This wearable ECG monitor market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Pet insurance refers to a policy purchased by a pet owner to offset the overall cost of their animal's medical bills. Pet insurance provides cover for veterinary fees if your pet is injured or becomes ill, and is a sensible approach to making sure this does not become a concern. The main types of policy coverage in pet insurance market are accident and illness and accident only. The accident and illness policy coverage are used to cover veterinary expenses incurred for the treatment of a pet who has endured an injury or is sick. Some pet insurance plans also cover death or loss of the pet that is insured. Pet insurance is available for animals such as dog and cat and are provide by public and private bodies. The global pet insurance market is segmented - 1) By Policy Coverage: Accident And Illness, Accident Only 2) By Animal Type: Dog, Cat 3) By Provider: Public, Private The global pet insurance market size will grow from $6.76 billion in 2022 to $7.82 billion in 2023 at a compound annual growth rate (CAGR) of 15.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the global pet insurance industry is expected to grow to $14.11 billion in 2027 at a CAGR of 15.9%. The increase in number of pet adoption is expected to continue during the forecast period driving pet insurance market. During the COVID-19 pandemic demand for adopting or fostering pets, rose worldwide, from Canada to India. Adopting pets help people by providing health benefits such as from lowering blood pressure to reducing stress, anxiety. For instance, according to PetPoint, between March and September 2020, U.S. homes number for foster pets increased by 8%. Similarly, according to Household, Income and Labour Dynamics in Australia (HILDA) Survey, published in 2020, two-thirds of Australians have at least one pet which accounted for 62% of surveyed people. The reports also indicate that around 72% of Australian pet owners have at least one dog and 37% have a least one cat. Thus increasing number of pet adoption will boost the growth of pet insurance market. Major players in the pet insurance market are Trupanion Inc., Deutsche Familienversicherung AG (DFV), Petplan (Allianz), Animal Friends Insurance Services Limited, Figo Pet Insurance LLC, Direct Line, Nationwide Mutual Insurance Company, Embrace Pet Insurance Agency LLC, Anicom Insurance, ipet Insurance Co. Ltd., Hartville Group, Pet Assure Corp., PetFirst, Royal & Sun Alliance (RSA), Agria Pet Insurance Ltd and 24PetWatch. Advancements and awareness in pet insurance have been a major trend in this market. Digital solution providers are looking to collaborate with insurers to enhance the customer experience for insureds through value-added services. Figo Pet Insurance, for example, offers the Figo Pet Cloud, a cloud-based service that allows for real-time pet GPS monitoring, medical records management, mobile claims submission, social pet profiles, a pet-friendly business directory, vaccination and appointment alerts via a smartphone app. Pet insurers should use a specialized digital marketing strategy to develop trust and connect with millennial customers. In October 2021, JAB Holding Co., a German-based conglomerate company, acquired Cardif Pinnacle for an undisclosed amount. Through the acquisition, the investment firm seeks to become a dominant player in the fast-growing animal health insurance industry. JAB's veterinary clinics have access to a lot of consumer spending data, which will help the company price premiums more properly. Cardif Pinnacle is a UK-based pet insurance subsidiary of BNP Paribas SA. North America was the largest region in the pet insurance market in 2022. The regions covered in the pet insurance market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the pet insurance market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The pet insurance market includes revenues earned by entities by providing services such as lifetime cover, time-limited cover and money-limit cover. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The pet insurance market research report is one of a series of new reports from The Business Research Company that provides pet insurance market statistics, including pet insurance industry global market size, regional shares, competitors with a pet insurance market share, detailed pet insurance market segments, market trends and opportunities, and any further data you may need to thrive in the pet insurance industry. This pet insurance market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Wearable blood pressure monitors are medical devices that can be worn by the user and measure the pressure of blood in the arteries. The main products in wearable blood pressure monitors are wrist blood pressure monitor, upper arm blood pressure monitor, and finger blood pressure monitor. The wrist blood pressure monitor refers to the devices that can be used at home by individuals to measure blood pressure. The various technologies involved in blood pressure monitors are Wi-Fi-based, Bluetooth based. These are used in hospitals, clinics, home care settings, and others. The global wearable blood pressure monitors market is segmented - 1) By Product: Wrist Blood Pressure Monitor, Upper Arm Blood Pressure Monitor, Finger Blood Pressure Monitor 2) By Technology: Wi-Fi Based, Bluetooth Based 3) By Application: Hospital, Clinic, Home Care Settings, Other Applications The global wearable blood pressure monitors market size will grow from $1.46 billion in 2022 to $1.77 billion in 2023 at a compound annual growth rate (CAGR) of 20.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the global wearable blood pressure monitors is expected to grow to $3.77 billion in 2027 at a CAGR of 20.9%. Increased demand for patient monitoring devices is expected to drive the wearable blood pressure monitors market. The increasing prevalence of chronic diseases coupled with the rise in surgeries that need continuous monitoring has mainly increased the demand for patient monitoring devices. Additionally, due to the growing awareness of a healthy lifestyle and fitness, individuals are interested in continuous monitoring of their health as it acts as a preventive measure while improving their health condition. The National Wearable Survey report by Valencell, a wearable technology company, states that two-thirds of customers owned a wearable device as they believe that it causes a positive impact on their health. Nearly 55% of the respondents are interested in monitoring their blood pressure with the help of wearable technologies. Therefore, increased demand for monitoring devices is expected to drive the wearable blood pressure market growth. Major players in the wearable blood pressure monitors market are Blipcare, GE Healthcare, ForaCare Suisse, Omron, Xiaomi, Philips, Medieval, Qardio, Smiths Group, and Tarilian Laser Technologies. With the increasing use of wearable technologies for healthcare services, the need for evaluating the accuracy and precision of these health trackers has increased in recent years. Studies showed that wearable technologies lack accuracy and precision which is likely to impact the market growth. There are growing concerns regarding the accuracy of wearables. Accuracy is very much important for some health conditions. Hypertension patients use wearable blood pressure monitors as their medications and treatment plans are based on blood pressure readings. Any wrong reading could be lethal. A study published by the journal Nature in February 2020, investigating sources of inaccuracy in wearable optical heart rate sensors, showed differences in heart rate on lighter skin and darker skin. Differences in readings among different wearable devices, and during rest and active conditions were also noted. Therefore, a lack of precision is expected to hinder the growth of the wearable blood pressure monitors market. Most of the wearable blood pressure monitoring technologies are under either experimental or research and development stage. Companies and researchers are studying different wearable technologies that monitor blood pressure. For instance, video from a smartphone is used to detect blood pressure by the variation in facial blood vessels. Valencell, a health-tech company, is working on an earbud sensor for detecting blood pressure using photoplethysmography. Also, the Akttia bracelet, a cuff-less technology that uses an optical sensor for monitoring blood pressure is under validation. Therefore, more R&D in this field is expected to provide growth opportunities for the wearable blood pressure market. North America was the largest region in the wearable blood pressure monitors market in 2022. Asia-Pacific was the second largest market in the global wearable blood pressure monitors market analysis. The regions covered in the global wearable blood pressure monitors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the wearable blood pressure monitors market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and USA. The wearable blood pressure monitors market consists of sales of instruments such as wrist blood pressure monitors, upper arm blood pressure monitors, and finger blood pressure monitors. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The wearable blood pressure monitors market research report is one of a series of new reports from The Business Research Company that provides wearable blood pressure monitors market statistics, including wearable blood pressure monitors industry global market size, regional shares, competitors with a wearable blood pressure monitors market share, detailed wearable blood pressure monitors market segments, market trends and opportunities, and any further data you may need to thrive in the wearable blood pressure monitors industry. This wearable blood pressure monitors market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.